Point72 Hong Kong’s Bristol-Myers Squibb BMY Stock Holding History

Point72 Hong Kong’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-174,100	Closed	-$12.4M	–	278
2022 Q3	$12.4M	Buy	174,100 +140,500	+418%	+$10.2M	0.43%	35
2022 Q2	$2.59M	Sell	33,600 -39,100	-54%	-$2.98M	0.1%	274
2022 Q1	$5.31M	Sell	72,700 -33,700	-32%	-$2.26M	0.18%	110
2021 Q4	$6.63M	Buy	106,400 +60,400	+131%	+$3.54M	0.23%	76
2021 Q3	$2.72M	Buy	46,000 +26,700	+138%	+$1.76M	0.09%	323
2021 Q2	$1.29M	Sell	19,300 -6,100	-24%	-$398K	0.04%	618
2021 Q1	$1.6M	Buy	25,400 +1,300	+5%	+$80.9K	0.05%	485
2020 Q4	$1.5M	Buy	+24,100	New	+$1.48M	0.07%	356

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Hong Kong's BMY Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Bristol-Myers Squibb (BMY) in Q3 2025: 132,171 shares worth $5.96M. The stake represents 0.27% of the portfolio and ranks #72 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in BMY as recently as Q4 2024.

Point72 Hong Kong first reported a position in BMY in Q1 2015 and has held it in 25 quarters since. The position peaked at $15.3M in Q4 2024. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

Point72 Hong Kong held 132,171 shares of Bristol-Myers Squibb worth $5.96M as of Q3 2025.
Bristol-Myers Squibb was a new Point72 Hong Kong position in Q3 2025.
Bristol-Myers Squibb made up 0.27% of Point72 Hong Kong's portfolio in Q3 2025, its #72 holding.
Point72 Hong Kong first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 25 quarters since.
Point72 Hong Kong's Bristol-Myers Squibb position peaked at $15.3M in Q4 2024.
2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.